Cargando…

Nasal nalbuphine analgesia in prehospital trauma managed by first-responder personnel on ski slopes in Switzerland: an observational cohort study

BACKGROUND: Pain is one of the major symptoms complained about by patients in the prehospital setting, especially in the case of trauma. When there is mountainous topography, as in Switzerland, there may be a time delay between injury and arrival of professional rescuers, in particular on ski slopes...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietsch, Urs, Berger, Yoël, Schurter, David, Theiler, Lorenz, Wenzel, Volker, Meuli, Lorenz, Grünenfelder, Andreas, Albrecht, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890875/
https://www.ncbi.nlm.nih.gov/pubmed/33596970
http://dx.doi.org/10.1186/s13049-021-00852-y
_version_ 1783652586712203264
author Pietsch, Urs
Berger, Yoël
Schurter, David
Theiler, Lorenz
Wenzel, Volker
Meuli, Lorenz
Grünenfelder, Andreas
Albrecht, Roland
author_facet Pietsch, Urs
Berger, Yoël
Schurter, David
Theiler, Lorenz
Wenzel, Volker
Meuli, Lorenz
Grünenfelder, Andreas
Albrecht, Roland
author_sort Pietsch, Urs
collection PubMed
description BACKGROUND: Pain is one of the major symptoms complained about by patients in the prehospital setting, especially in the case of trauma. When there is mountainous topography, as in Switzerland, there may be a time delay between injury and arrival of professional rescuers, in particular on ski slopes. Administration of a safe opioid by first responders may improve overall treatment. We therefore assessed administration of nasal nalbuphine as an analgesic treatment for trauma patients in Switzerland. METHODS: This observational cohort study examined 267 patients who were treated with nasal nalbuphine by first responders in six ski resorts in Switzerland. All first responders were instructed to begin treatment by assessing the feasibility of using nalbuphine to treat pain in the patient. A treatment algorithm was developed and distributed to assure that nalbuphine was only administered following a strict protocol. Data regarding pain scores and pain reduction after administration of nalbuphine were collected on-site. Refills were handed out to the first responders with the return of each completed questionnaire. RESULTS: Nalbuphine provided effective pain relief, with the median level of pain on the numeric rating scale for pain reduced by 3 units on average, from 8 points (p < 0.001). The multivariate regression model showed that pain reduction was more pronounced in patients with higher initial pain levels. Nalbuphine was more effective in adolsecents than in patients aged 20 to 60 years (p = 0.006). No major side effects were observed. CONCLUSION: Nasal administration of nalbuphine by first responders is a presumably safe and effective noninvasive pain management strategy for acutely injured patients in the prehospital setting. This may be an alternative, especially in the case of severe pain and prolonged time between arrival of the first responders and arrival of EMS/HEMS personnel on scene.
format Online
Article
Text
id pubmed-7890875
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78908752021-02-22 Nasal nalbuphine analgesia in prehospital trauma managed by first-responder personnel on ski slopes in Switzerland: an observational cohort study Pietsch, Urs Berger, Yoël Schurter, David Theiler, Lorenz Wenzel, Volker Meuli, Lorenz Grünenfelder, Andreas Albrecht, Roland Scand J Trauma Resusc Emerg Med Original Research BACKGROUND: Pain is one of the major symptoms complained about by patients in the prehospital setting, especially in the case of trauma. When there is mountainous topography, as in Switzerland, there may be a time delay between injury and arrival of professional rescuers, in particular on ski slopes. Administration of a safe opioid by first responders may improve overall treatment. We therefore assessed administration of nasal nalbuphine as an analgesic treatment for trauma patients in Switzerland. METHODS: This observational cohort study examined 267 patients who were treated with nasal nalbuphine by first responders in six ski resorts in Switzerland. All first responders were instructed to begin treatment by assessing the feasibility of using nalbuphine to treat pain in the patient. A treatment algorithm was developed and distributed to assure that nalbuphine was only administered following a strict protocol. Data regarding pain scores and pain reduction after administration of nalbuphine were collected on-site. Refills were handed out to the first responders with the return of each completed questionnaire. RESULTS: Nalbuphine provided effective pain relief, with the median level of pain on the numeric rating scale for pain reduced by 3 units on average, from 8 points (p < 0.001). The multivariate regression model showed that pain reduction was more pronounced in patients with higher initial pain levels. Nalbuphine was more effective in adolsecents than in patients aged 20 to 60 years (p = 0.006). No major side effects were observed. CONCLUSION: Nasal administration of nalbuphine by first responders is a presumably safe and effective noninvasive pain management strategy for acutely injured patients in the prehospital setting. This may be an alternative, especially in the case of severe pain and prolonged time between arrival of the first responders and arrival of EMS/HEMS personnel on scene. BioMed Central 2021-02-17 /pmc/articles/PMC7890875/ /pubmed/33596970 http://dx.doi.org/10.1186/s13049-021-00852-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Original Research
Pietsch, Urs
Berger, Yoël
Schurter, David
Theiler, Lorenz
Wenzel, Volker
Meuli, Lorenz
Grünenfelder, Andreas
Albrecht, Roland
Nasal nalbuphine analgesia in prehospital trauma managed by first-responder personnel on ski slopes in Switzerland: an observational cohort study
title Nasal nalbuphine analgesia in prehospital trauma managed by first-responder personnel on ski slopes in Switzerland: an observational cohort study
title_full Nasal nalbuphine analgesia in prehospital trauma managed by first-responder personnel on ski slopes in Switzerland: an observational cohort study
title_fullStr Nasal nalbuphine analgesia in prehospital trauma managed by first-responder personnel on ski slopes in Switzerland: an observational cohort study
title_full_unstemmed Nasal nalbuphine analgesia in prehospital trauma managed by first-responder personnel on ski slopes in Switzerland: an observational cohort study
title_short Nasal nalbuphine analgesia in prehospital trauma managed by first-responder personnel on ski slopes in Switzerland: an observational cohort study
title_sort nasal nalbuphine analgesia in prehospital trauma managed by first-responder personnel on ski slopes in switzerland: an observational cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890875/
https://www.ncbi.nlm.nih.gov/pubmed/33596970
http://dx.doi.org/10.1186/s13049-021-00852-y
work_keys_str_mv AT pietschurs nasalnalbuphineanalgesiainprehospitaltraumamanagedbyfirstresponderpersonnelonskislopesinswitzerlandanobservationalcohortstudy
AT bergeryoel nasalnalbuphineanalgesiainprehospitaltraumamanagedbyfirstresponderpersonnelonskislopesinswitzerlandanobservationalcohortstudy
AT schurterdavid nasalnalbuphineanalgesiainprehospitaltraumamanagedbyfirstresponderpersonnelonskislopesinswitzerlandanobservationalcohortstudy
AT theilerlorenz nasalnalbuphineanalgesiainprehospitaltraumamanagedbyfirstresponderpersonnelonskislopesinswitzerlandanobservationalcohortstudy
AT wenzelvolker nasalnalbuphineanalgesiainprehospitaltraumamanagedbyfirstresponderpersonnelonskislopesinswitzerlandanobservationalcohortstudy
AT meulilorenz nasalnalbuphineanalgesiainprehospitaltraumamanagedbyfirstresponderpersonnelonskislopesinswitzerlandanobservationalcohortstudy
AT grunenfelderandreas nasalnalbuphineanalgesiainprehospitaltraumamanagedbyfirstresponderpersonnelonskislopesinswitzerlandanobservationalcohortstudy
AT albrechtroland nasalnalbuphineanalgesiainprehospitaltraumamanagedbyfirstresponderpersonnelonskislopesinswitzerlandanobservationalcohortstudy